IQUIBICEN   23947
INSTITUTO DE QUIMICA BIOLOGICA DE LA FACULTAD DE CIENCIAS EXACTAS Y NATURALES
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
Advances in the development of an in vitro test for detection of tuberculosis infection
Autor/es:
AMIANO NICOLAS O; TATEOSIAN NANCY L; HERNANDEZ DEL PINO RODRIGO; LEVI ALBERTO; MORELLI MARIA PAULA; PELLEGRINI JOAQUIN M; CHULUYAN EDUARDO H; CASTELLO FLORENCIA A; PALMERO DOMINGO J; ROLANDELLI AGUSTIN; IOVANNA JUAN; GARCÍA VERÓNICA E
Lugar:
Mar del Plata
Reunión:
Congreso; LXI Reunión Científica Anual de la Sociedad Argentina de Investigaciones Clinicas (SAIC), LXIV Reunión Anual de la Sociedad Argentina de Inmunología (SAI) y XLVIII Reunión Anual de la Sociedad Argentina de Farmacología Experimental (SAFE); 2016
Institución organizadora:
Sociedad Argentina de Inmunologia (SAI)
Resumen:
Current IFNγ release assays (IGRAs) cannot discriminate active and latent infection with Mycobacterium tuberculosis (Mtb). Moreover, no gold standard to diagnosis latent tuberculosis (LTBI) is available. Previously, we demonstrated that the dormancy antigen Rv2626c and six peptide-pools derived from its sequence discriminated by IFN-γ secretion LTBI subjects from healthy donors (HD) and tuberculosis (TB) patients. Stimulation of peripheral blood mononuclear cells (PBMCs) or whole blood with peptides or Rv2626c induced differential amounts of IFN-γ among the groups. The aim of this work was to advance in the development of a diagnostic kit to detect tuberculosis infection. For this, we focused on two main objectives: i) To develop new immunogenic pools with less than six peptides to diminish costs and ii) To use new pools to evaluate their immunogenicity in whole blood incubated in polystyrene tubes (as used by QuantiFERON-TB - QFT). IFNγ release was measured by ELISA. To design new pools we first stimulated LTBI PBMCs with all the individual peptides (13-15 mers, overlapped by 11 aa; 36 in total, covering the complete Rv2626c sequence). Peptides 1, 2, 3, 5, 12, 22, 23, 30 and 36 were the more immunogenic peptides. Then, we generated the new pools , BD, IM1, IM2, IM3 and PBMCs were stimulated with them (37º, 5d). We found that treatment with these pools significantly differentiate among the groups. Furthermore, when we stimulated whole blood with these pools (37º, 16h) we observed that pool IM2 clearly differentiated LTBI individuals from HD and TB (0.4730.020 IU/mL of IFNγ (LTBI), 0.0950.030 (HD), 0.0080.008 (TB); p